A detailed history of Humankind Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Humankind Investments LLC holds 14,117 shares of ABBV stock, worth $2.34 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
14,117
Previous 16,692 15.43%
Holding current value
$2.34 Million
Previous $2.59 Million 0.62%
% of portfolio
0.69%
Previous 0.78%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $411,536 - $468,907
-2,575 Reduced 15.43%
14,117 $2.57 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $165,808 - $186,738
1,205 Added 7.78%
16,692 $2.59 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $82,425 - $95,419
-617 Reduced 3.83%
15,487 $2.31 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $227,254 - $282,803
1,715 Added 11.92%
16,104 $2.17 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $71,003 - $81,771
491 Added 3.53%
14,389 $2.29 Million
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $182,707 - $219,114
-1,321 Reduced 8.68%
13,898 $0
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $425,177 - $487,650
3,168 Added 26.29%
15,219 $2.04 Million
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $163,767 - $208,202
1,190 Added 10.96%
12,051 $1.85 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $275,574 - $341,910
-2,088 Reduced 16.12%
10,861 $1.76 Million
Q4 2021

Mar 21, 2022

BUY
$107.43 - $135.93 $167,590 - $212,050
1,560 Added 13.7%
12,949 $1.75 Million
Q3 2021

Mar 21, 2022

BUY
$106.4 - $120.78 $242,804 - $275,619
2,282 Added 25.06%
11,389 $1.23 Million
Q2 2021

Mar 21, 2022

BUY
$105.21 - $117.21 $330,990 - $368,742
3,146 Added 52.78%
9,107 $1.03 Million
Q1 2021

Mar 21, 2022

BUY
$102.3 - $112.62 $609,810 - $671,327
5,961 New
5,961 $645,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.